Leucadia National Corp Buys New Stake in Mead Johnson Nutrition Company (MJN)

Leucadia National Corp bought a new stake in Mead Johnson Nutrition Company (NYSE:MJN) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 50,000 shares of the company’s stock, valued at approximately $4,454,000. Mead Johnson Nutrition Company accounts for 0.4% of Leucadia National Corp’s holdings, making the stock its 22nd largest position.

Other large investors have also recently added to or reduced their stakes in the company. Norges Bank purchased a new stake in Mead Johnson Nutrition Company during the fourth quarter valued at about $102,498,000. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main purchased a new stake in Mead Johnson Nutrition Company during the fourth quarter valued at about $71,465,000. Vivaldi Asset Management LLC purchased a new stake in Mead Johnson Nutrition Company during the first quarter valued at about $70,704,000. Nuance Investments LLC purchased a new stake in Mead Johnson Nutrition Company during the first quarter valued at about $67,875,000. Finally, Two Sigma Investments LP raised its stake in Mead Johnson Nutrition Company by 138.4% in the fourth quarter. Two Sigma Investments LP now owns 991,797 shares of the company’s stock valued at $70,180,000 after buying an additional 575,750 shares in the last quarter. 88.40% of the stock is owned by institutional investors.

Institutional Ownership by Quarter for Mead Johnson Nutrition Company (NYSE:MJN)

Mead Johnson Nutrition Company (NYSE:MJN) remained flat at $89.98 on Monday. Mead Johnson Nutrition Company has a 52 week low of $69.25 and a 52 week high of $94.40. The stock has a 50-day moving average of $89.32 and a 200 day moving average of $83.18. The company has a market cap of $16.52 billion, a P/E ratio of 28.27 and a beta of 1.57.

Mead Johnson Nutrition Company (NYSE:MJN) last posted its quarterly earnings data on Thursday, April 27th. The company reported $0.80 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.79 by $0.01. Mead Johnson Nutrition Company had a negative return on equity of 135.60% and a net margin of 16.16%. The firm had revenue of $883.50 million during the quarter, compared to the consensus estimate of $911.63 million. During the same period in the prior year, the company earned $0.87 EPS. The firm’s revenue was down 8.2% compared to the same quarter last year. On average, analysts forecast that Mead Johnson Nutrition Company will post $3.20 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 5th. Investors of record on Tuesday, June 20th will be paid a $0.4125 dividend. This represents a $1.65 annualized dividend and a yield of 1.83%. The ex-dividend date is Friday, June 16th. Mead Johnson Nutrition Company’s dividend payout ratio is currently 51.72%.

COPYRIGHT VIOLATION WARNING: “Leucadia National Corp Buys New Stake in Mead Johnson Nutrition Company (MJN)” was first posted by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this story can be read at https://sportsperspectives.com/2017/06/19/leucadia-national-corp-buys-new-stake-in-mead-johnson-nutrition-company-mjn.html.

MJN has been the subject of a number of research analyst reports. Zacks Investment Research lowered shares of Mead Johnson Nutrition Company from a “hold” rating to a “sell” rating in a report on Friday, April 28th. Wells Fargo & Company lowered shares of Mead Johnson Nutrition Company from an “outperform” rating to a “market perform” rating and set a $89.00 price objective for the company. in a report on Monday, April 3rd. Credit Suisse Group lowered shares of Mead Johnson Nutrition Company from an “outperform” rating to a “neutral” rating and set a $90.00 price objective for the company. in a report on Sunday, March 5th. Citigroup Inc. lowered shares of Mead Johnson Nutrition Company from a “buy” rating to a “neutral” rating in a report on Monday, March 6th. Finally, BidaskClub raised shares of Mead Johnson Nutrition Company from a “sell” rating to a “hold” rating in a report on Wednesday, June 14th. Two equities research analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $84.83.

About Mead Johnson Nutrition Company

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, Latin America and North America/Europe. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.

Receive News & Ratings for Mead Johnson Nutrition Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mead Johnson Nutrition Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply